Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 226 participants.
Also called NCT02408120
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose health services research
- Phase
- Phase 4
- Enrolled
- 226 participants
- Sponsor
- Registry
-
NCT02408120
-
- Other papers using this trial's data
- Efficacy and Safety of Intensive Versus Nonintensive Supplemental Insulin With a Basal-Bolus Insulin Regimen in Hospitalized Patients With Type 2 Diabetes: A Randomized Clinical Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02408120. Randomized; no masking; primary purpose health services research. Start 2015-10 (registry gives no type); primary completion 2019-12-11 (actual). Results posted on 2021-01-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Insulin glargine
- Intervention (Drug)
- Insulin aspart
- Intervention (Drug)
- Supplemental insulin aspart
- Lead sponsor
- Emory University
Record details
- Record id
cardio:ct-nct02408120- Content hash
f47b9db3298d107b62c77c40ec6899db0203c2ddda8f56b2521465925054bc69